Medical News

RSS

Tobacco smoke linked with respiratory diseases

Tobacco smoke is involved in uncontrolled asthma, a diminished response to anti-asthma drugs, rhinitis, nasal obstruction, and deregulation of the immune system according to an international expert at the annual meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Miami Beach, Fla.

9 Nov 2009

Warner Chilcott reports a net income of $424.2M for the quarter ended September 30, 2009

Warner Chilcott plc today announced its results for the quarter ended September 30, 2009. Revenue in the quarter ended September 30, 2009 increased 9.0% to $252.8 million over the prior year quarter. The primary drivers of the increase in revenue in the quarter were the net sales of LOESTRIN 24 FE and ESTRACE Cream which were partially offset by net sales declines of other products, primarily TACLONEX.

9 Nov 2009

Caliper Life Sciences announces financial results for third quarter ended September 30, 2009

Caliper Life Sciences, Inc. today reported results for its third quarter ended September 30, 2009. GAAP revenues increased by 4% to $32.2 million, from non-GAAP revenues of $31.0 million in the same period of 2008, which represents GAAP revenue of $34.0 million in the third quarter of 2008 reduced by $3.0 million for the impact of divested product lines.

9 Nov 2009

Cytori Therapeutics announces financial results for the third quarter of 2009

Cytori Therapeutics is reporting its financial results for the quarter and nine months ended September 30, 2009.

9 Nov 2009

Brand identity of Asymtek to be changed to Nordson ASYMTEK

Asymtek, a leader in dispensing, coating, and jetting technologies, announces that it will soon begin a process of refreshing its visual brand identity and be known as Nordson ASYMTEK. This modification is part of an initiative by its parent company, Nordson Corporation, to identify its businesses in the marketplace more clearly and consistently. All other aspects of what was formerly called "Asymtek" will remain the same.

9 Nov 2009

Concert Pharmaceuticals commences Phase 1b clinical study of its CTP-518 HIV protease inhibitor

Concert Pharmaceuticals, Inc. announced today that it has initiated a Phase 1b clinical study with CTP-518, its investigational oral HIV protease inhibitor for the treatment of HIV infection. In connection with the start of this multiple ascending dose arm of the Phase 1 study, Concert will receive a $12 million milestone payment under the company’s strategic alliance with GlaxoSmithKline.

9 Nov 2009

Bovie Medical Corporation total revenues decreases in third quarter 2009

Bovie Medical Corporation, a manufacturer and marketer of electrosurgical products, today announced its financial results for the third quarter ended September 30, 2009.

9 Nov 2009

Sunrise Senior Living reports revenues of $382.6M for the third quarter of 2009

Sunrise Senior Living, Inc. today reported financial results and operating data for the third quarter of 2009. Sunrise will host a conference call and webcast Monday, November 9, 2009, at 9:00 a.m. ET, to discuss the financial results.

9 Nov 2009

First Edition: November 9, 2009

Two mornings after, the headlines are still focused on the landmark House passage of the Democratic-backed health overhaul bill and what might happen next... in the Senate.

9 Nov 2009

First-quarter fiscal 2010 results announced by Rural/Metro

Rural/Metro Corporation, a leading provider of ambulance and private fire protection services, announced results today for its fiscal 2010 first quarter, reporting continued growth in net revenue, strong cash flows, and further improvements in key operating statistics.

9 Nov 2009

AMRI reports $47.7 million total revenue for the third quarter of 2009

AMRI today reported financial and operating results for the third quarter ended September 30, 2009.

9 Nov 2009

American Heart Association commends passage of Affordable Health Care for America Act

Today's dramatic vote in the U.S. House of Representatives brings us one step closer to meaningful health care reform. We are very pleased that the Affordable Health Care for America Act makes health care more accessible and affordable for millions of Americans by enhancing coverage, promoting preventive care and improving delivery of care. But this milestone also serves as a sober reminder of the tremendous amount of work we still have before us if we are to ensure that legislation that ultimately emerges from Congress and is sent to the President retains the patient protections and provisions that are in line with the association's tenets of health care reform and are so important to individuals struggling with heart disease and stroke and their families.

9 Nov 2009

Caliper Discovery Alliances and Services receives a $1.8M funding commitment for the EPA's ToxCast program

Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery and life sciences research, today announced that its Caliper Discovery Alliances and Services (CDAS) unit has been awarded a new funding commitment for $1.8 million under its contract with the Environmental Protection Agency (EPA) for the EPA's ToxCast screening program.

9 Nov 2009

BrainStorm Cell Therapeutics' approach for treating neurodegenerative diseases shown to be effective

BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies and therapeutics, is pleased to announce that the company’s therapeutic approach for treating neurodegenerative diseases was shown to be superior to other current potential stem cell treatments.

9 Nov 2009

Simcere Pharmaceutical Group signs agreement to acquire manufacturing license from Tianjin Tianda Pharmaceutical

Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced an agreement to acquire the manufacturing license in China of Rosuvastatin from Tianjin Tianda Pharmaceutical Co., Ltd. ("Tianda").

9 Nov 2009

Health care executive panel to discus challenges in interoperability between health information networks

A panel of executives representing public-sector health, health care providers, health care information technology, and health plans will address the value of collaboration and the challenges inherent to interoperability, especially as both topics pertain to health information networks.

9 Nov 2009

Breast Fest Film Festival to focus on storytelling as part of the healing process

After a successful inaugural year, the world's first breast cancer film festival is back and bigger than ever. Along with a new selection of inspiring films that cover the emotional spectrum of the breast cancer journey, Rethink Breast Cancer's 2009 Breast Fest Film Festival is unveiling a new three-day program to include additional workshops to further engage and educate audiences.

9 Nov 2009

SuperGen to stage presentations to review clinical and non-clinical advances in different compounds

SuperGen, Inc., a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced the acceptance of seven abstracts for poster presentations on November 16, 17 and 18, 2009 at the 2009 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics conference in Boston, MA.

9 Nov 2009

Nasdaq grants Anesiva's request for continued listing on The NASDAQ Global Market

Anesiva, Inc. today announced that on November 5, 2009, it received a letter from The NASDAQ Stock Market LLC stating that the Nasdaq Hearing Panel has granted Anesiva's request for continued listing on The NASDAQ Global Market subject to the condition that Anesiva shall have completed on or before December 31, 2009, the proposed merger (the "Merger") contemplated by the Agreement and Plan of Merger, dated August 4, 2009, among Anesiva, Arca Acquisition Corporation ("Arca"), a wholly-owned subsidiary of Anesiva, Arcion Therapeutics, Inc. ("Arcion") and, with respect to Articles V and IX only of the agreement, each of the Arcion stockholders listed on Schedule I thereto.

9 Nov 2009

PAREXEL International forms an alliance with Mortara Instrument, enhances cardiac safety capabilities

PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced that it has enhanced its cardiac safety capabilities for early phase clinical development through an alliance with Mortara Instrument, Inc., which manufactures and distributes electrocardiogram (ECG) devices and related technology worldwide.

From Parexel 9 Nov 2009

Medical News

Tobacco smoke linked with respiratory diseases

Warner Chilcott reports a net income of $424.2M for the quarter ended September 30, 2009

Caliper Life Sciences announces financial results for third quarter ended September 30, 2009

Cytori Therapeutics announces financial results for the third quarter of 2009

Brand identity of Asymtek to be changed to Nordson ASYMTEK

Concert Pharmaceuticals commences Phase 1b clinical study of its CTP-518 HIV protease inhibitor

Bovie Medical Corporation total revenues decreases in third quarter 2009

Sunrise Senior Living reports revenues of $382.6M for the third quarter of 2009

First Edition: November 9, 2009

First-quarter fiscal 2010 results announced by Rural/Metro

AMRI reports $47.7 million total revenue for the third quarter of 2009

American Heart Association commends passage of Affordable Health Care for America Act

Caliper Discovery Alliances and Services receives a $1.8M funding commitment for the EPA's ToxCast program

BrainStorm Cell Therapeutics' approach for treating neurodegenerative diseases shown to be effective

Simcere Pharmaceutical Group signs agreement to acquire manufacturing license from Tianjin Tianda Pharmaceutical

Health care executive panel to discus challenges in interoperability between health information networks

Breast Fest Film Festival to focus on storytelling as part of the healing process

SuperGen to stage presentations to review clinical and non-clinical advances in different compounds

Nasdaq grants Anesiva's request for continued listing on The NASDAQ Global Market

PAREXEL International forms an alliance with Mortara Instrument, enhances cardiac safety capabilities

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News